SCM
ABBV icon

Suffolk Capital Management’s AbbVie ABBV Stock Holding History

Suffolk Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,335
Closed -$348K – 123
2017
Q1 		$348K Sell
5,335
-903
-14% -$56.8K 0.05% 128
2016
Q4 		$391K Hold
6,238
– – 0.05% 130
2016
Q3 		$393K Sell
6,238
-31,495
-83% -$2.04M 0.05% 130
2016
Q2 		$2.34M Buy
+37,733
New +$2.3M 0.3% 102
2015
Q4 		– Sell
-19,747
Closed -$1.07M – 137
2015
Q3 		$1.07M Buy
+19,747
New +$1.29M 0.14% 129

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Suffolk Capital Management's ABBV Position: Q2 2017 in Review

Suffolk Capital Management sold out of AbbVie (ABBV) in Q2 2017, closing a stake of 5,335 shares — an estimated $348K sold.

Suffolk Capital Management first reported a position in ABBV in Q3 2015 and held it in 5 quarters. The position peaked at $2.34M in Q2 2016. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Suffolk Capital Management reported no remaining AbbVie position as of Q2 2017 after selling out during the quarter.
  • Suffolk Capital Management sold 5,335 AbbVie shares in Q2 2017, an estimated $348K.
  • Suffolk Capital Management first reported a position in AbbVie in Q3 2015 and held it in 5 quarters.
  • Suffolk Capital Management's AbbVie position peaked at $2.34M in Q2 2016.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Suffolk Capital Management's 13F filing for Q2 2017, filed 28 Jul 2017.